GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Coloplast AS (LTS:0QBO) » Definitions » Cyclically Adjusted FCF per Share

Coloplast AS (LTS:0QBO) Cyclically Adjusted FCF per Share : kr16.19 (As of Sep. 2024)


View and export this data going back to 2007. Start your Free Trial

What is Coloplast AS Cyclically Adjusted FCF per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Coloplast AS's adjusted free cash flow per share for the three months ended in Sep. 2024 was kr7.113. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is kr16.19 for the trailing ten years ended in Sep. 2024.

During the past 12 months, Coloplast AS's average Cyclically Adjusted FCF Growth Rate was -3.60% per year. During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was 3.40% per year. During the past 5 years, the average Cyclically Adjusted FCF Growth Rate was 5.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of Coloplast AS was 9.70% per year. The lowest was 3.40% per year. And the median was 8.30% per year.

As of today (2024-12-13), Coloplast AS's current stock price is kr831.50. Coloplast AS's Cyclically Adjusted FCF per Share for the quarter that ended in Sep. 2024 was kr16.19. Coloplast AS's Cyclically Adjusted Price-to-FCF of today is 51.36.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Coloplast AS was 86.54. The lowest was 41.66. And the median was 57.59.


Coloplast AS Cyclically Adjusted FCF per Share Historical Data

The historical data trend for Coloplast AS's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Coloplast AS Cyclically Adjusted FCF per Share Chart

Coloplast AS Annual Data
Trend Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 13.86 14.59 16.64 16.75 16.19

Coloplast AS Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 16.75 17.16 15.82 16.06 16.19

Competitive Comparison of Coloplast AS's Cyclically Adjusted FCF per Share

For the Medical Instruments & Supplies subindustry, Coloplast AS's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Coloplast AS's Cyclically Adjusted Price-to-FCF Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Coloplast AS's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Coloplast AS's Cyclically Adjusted Price-to-FCF falls into.



Coloplast AS Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Coloplast AS's adjusted Free Cash Flow per Share data for the three months ended in Sep. 2024 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Sep. 2024 (Change)*Current CPI (Sep. 2024)
=7.113/118.9000*118.9000
=7.113

Current CPI (Sep. 2024) = 118.9000.

Coloplast AS Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201412 2.313 99.400 2.767
201503 0.211 100.200 0.250
201506 4.556 100.300 5.401
201509 5.713 100.200 6.779
201512 2.369 99.800 2.822
201603 1.703 100.200 2.021
201606 2.112 100.600 2.496
201609 5.020 100.200 5.957
201612 0.669 100.300 0.793
201703 0.725 101.200 0.852
201706 4.470 101.200 5.252
201709 6.196 101.800 7.237
201712 3.813 101.300 4.475
201803 1.320 101.700 1.543
201806 5.540 102.300 6.439
201809 6.715 102.400 7.797
201812 3.014 102.100 3.510
201903 1.498 102.900 1.731
201906 5.697 102.900 6.583
201909 7.254 102.900 8.382
201912 3.784 102.900 4.372
202003 1.689 103.300 1.944
202006 5.696 103.200 6.563
202009 6.788 103.500 7.798
202012 -0.085 103.400 -0.098
202103 2.430 104.300 2.770
202106 5.420 105.000 6.138
202109 7.824 105.800 8.793
202112 4.361 106.600 4.864
202203 -0.089 109.900 -0.096
202206 6.182 113.600 6.470
202209 8.189 116.400 8.365
202212 0.998 115.900 1.024
202303 1.874 117.300 1.900
202306 4.128 116.400 4.217
202309 6.662 117.400 6.747
202312 6.920 116.700 7.050
202403 -12.612 118.400 -12.665
202406 5.062 118.500 5.079
202409 7.113 118.900 7.113

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.


Coloplast AS  (LTS:0QBO) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Coloplast AS's Cyclically Adjusted Price-to-FCF of today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/Cyclically Adjusted FCF per Share
=831.50/16.19
=51.36

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Coloplast AS was 86.54. The lowest was 41.66. And the median was 57.59.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Coloplast AS Cyclically Adjusted FCF per Share Related Terms

Thank you for viewing the detailed overview of Coloplast AS's Cyclically Adjusted FCF per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Coloplast AS Business Description

Address
Holtedam 1-3, Humlebaek, DNK, DK-3050
Coloplast is a leading global competitor in ostomy management and continence care. The firm designs, manufactures, and markets ostomy care systems, disposable containment devices, paste, powder, seals, and intermittent catheters for continence care. Coloplast also maintains a tertiary presence in the urology and woundcare markets, where it manufactures and markets penile implants, slings for incontinence and prolapse, and wound dressings. The company derives more than 60% of sales from Europe, 24% from other developed countries, and 17% from the rest of the world.

Coloplast AS Headlines

No Headlines